Qure healthcair AI technologies firm from Mumbai, India have closed $65m Series D round. This round was co-led by Lightspeed and 360 ONE Asset, with the support of Merck Global Health Innovation Fund, Kae Capital as well as, Lightspeed; Novo Holdings, Health Quad; and TeamFund.
Purpose of Funding
The company intends to fund the expansion of operation in the US and other markets with the newly raised capital. Furthermore, Qure.ai will explore the enhancement of basic AI models should be done and acquisition of related med-tech firms.
About Qure.ai
Qure.ai was established in 2016 and was helmed by its current CEO, Prashant Warier and discusses the issue of inequality in healthcare. AI enabled solutions offered by AIO cause are in over 90 global locations at 3000 plus centers to assist the identification and management of essential diseases.
The software of Qure has 18 clearances from FDA and has Class IIb accreditation based on EU MDR standards. Currently the company is an international firm and it has offices in New York, London and Dubai.
**To get all Indian Startup news Please Visit – https://growwseed.com/category/india-startup-funding-news/
